Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.

Hanash AM, Kappel LW, Yim NL, Nejat RA, Goldberg GL, Smith OM, Rao UK, Dykstra L, Na IK, Holland AM, Dudakov JA, Liu C, Murphy GF, Leonard WJ, Heller G, van den Brink MR.

Blood. 2011 Jul 14;118(2):446-55. doi: 10.1182/blood-2010-07-294785. Epub 2011 May 19.

PMID:
21596854
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL.

J Clin Invest. 1999 Aug;104(3):317-25.

PMID:
10430613
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Altered effector CD4+ T cell function in IL-21R-/- CD4+ T cell-mediated graft-versus-host disease.

Oh I, Ozaki K, Meguro A, Hatanaka K, Kadowaki M, Matsu H, Tatara R, Sato K, Iwakura Y, Nakae S, Sudo K, Teshima T, Leonard WJ, Ozawa K.

J Immunol. 2010 Aug 1;185(3):1920-6. doi: 10.4049/jimmunol.0902217. Epub 2010 Jun 23.

PMID:
20574002
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells.

Meguro A, Ozaki K, Hatanaka K, Oh I, Sudo K, Ohmori T, Matsu H, Tatara R, Sato K, Sakata Y, Nakae S, Leonard WJ, Ozawa K.

Bone Marrow Transplant. 2011 Dec;46(12):1557-65. doi: 10.1038/bmt.2010.342. Epub 2011 Jan 24.

PMID:
21258423
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.

Couturier M, Lamarthée B, Arbez J, Renauld JC, Bossard C, Malard F, Bonnefoy F, Mohty M, Perruche S, Tiberghien P, Saas P, Gaugler B.

Leukemia. 2013 Jul;27(7):1527-37. doi: 10.1038/leu.2013.39. Epub 2013 Feb 12.

PMID:
23399894
[PubMed - indexed for MEDLINE]
6.

Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.

Imado T, Iwasaki T, Kuroiwa T, Sano H, Hara H.

Transplantation. 2004 Feb 15;77(3):391-8.

PMID:
14966413
[PubMed - indexed for MEDLINE]
7.

Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.

Yang YG, Sergio JJ, Pearson DA, Szot GL, Shimizu A, Sykes M.

Blood. 1997 Dec 1;90(11):4651-60.

PMID:
9373279
[PubMed - indexed for MEDLINE]
Free Article
8.

Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease.

Tawara I, Maeda Y, Sun Y, Lowler KP, Liu C, Toubai T, McKenzie AN, Reddy P.

Exp Hematol. 2008 Aug;36(8):988-96. doi: 10.1016/j.exphem.2008.02.010. Epub 2008 Apr 14.

PMID:
18410989
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.

Das R, Komorowski R, Hessner MJ, Subramanian H, Huettner CS, Cua D, Drobyski WR.

Blood. 2010 Jun 24;115(25):5249-58. doi: 10.1182/blood-2009-11-255422. Epub 2010 Apr 9.

PMID:
20382845
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation.

Schmaltz C, Alpdogan O, Muriglan SJ, Kappel BJ, Rotolo JA, Ricchetti ET, Greenberg AS, Willis LM, Murphy GF, Crawford JM, van den Brink MR.

Blood. 2003 Mar 15;101(6):2440-5. Epub 2002 Nov 7.

PMID:
12424195
[PubMed - indexed for MEDLINE]
Free Article
11.

IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.

Nguyen V, Luzina I, Rus H, Tegla C, Chen C, Rus V.

J Immunol. 2012 Jul 15;189(2):1081-93. doi: 10.4049/jimmunol.1200318. Epub 2012 Jun 20.

PMID:
22723520
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.

Reddy P, Teshima T, Hildebrandt G, Williams DL, Liu C, Cooke KR, Ferrara JL.

Blood. 2003 Apr 1;101(7):2877-85. Epub 2002 Nov 14.

PMID:
12433681
[PubMed - indexed for MEDLINE]
Free Article
13.

The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.

Yang YG, Sykes M.

Leuk Lymphoma. 1999 May;33(5-6):409-20. Review.

PMID:
10342569
[PubMed - indexed for MEDLINE]
14.

Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.

Yang YG, Qi J, Wang MG, Sykes M.

Blood. 2002 Jun 1;99(11):4207-15.

PMID:
12010827
[PubMed - indexed for MEDLINE]
Free Article
15.

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.

Fowler DH, Gress RE.

Leuk Lymphoma. 2000 Jul;38(3-4):221-34. Review.

PMID:
10830730
[PubMed - indexed for MEDLINE]
16.

Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.

Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K, Tanimoto M, Teshima T.

J Clin Invest. 2010 Jul;120(7):2370-8. doi: 10.1172/JCI39165. Epub 2010 Jun 7.

PMID:
20530875
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, LeBon T, Kandeel F, Forman S, Zeng D.

Blood. 2008 Sep 1;112(5):2101-10. doi: 10.1182/blood-2007-12-126987. Epub 2008 Jul 2.

PMID:
18596226
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.

Johnson BD, Becker EE, Truitt RL.

Biol Blood Marrow Transplant. 1999;5(3):123-32.

PMID:
10392958
[PubMed - indexed for MEDLINE]
19.

Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.

Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.

Eur J Haematol. 2008 Sep;81(3):226-35. doi: 10.1111/j.1600-0609.2008.01108.x. Epub 2008 Jun 28.

PMID:
18573173
[PubMed - indexed for MEDLINE]
20.

Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.

Zeis M, Uharek L, Hartung G, Glass B, Steinmann J, Schmitz N.

Hematol J. 2001;2(2):136-44.

PMID:
11424006
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk